Literature DB >> 8062935

Epidemiology, etiology, and fertility drugs in ovarian epithelial carcinoma: where are we today?

Z Shoham1.   

Abstract

OBJECTIVE: To review studies that have examined the epidemiology and etiology of the development of epithelial carcinoma of the ovary. DATA IDENTIFICATION: Important published studies related to the topic were identified through a computerized bibliography search.
CONCLUSION: A review of the literature reveals that the etiology of epithelial ovarian cancer is probably multifactorial and that genetic, environmental, hormonal, and viral factors appear to be directly or indirectly related to the development of the disease. An attempt to implicate specific agents has not produced conclusive results. However, based on large epidemiologic studies, it seems that there is a clear trend of decreasing risk with increasing number of pregnancies, deliveries, use of oral contraceptives, and the duration of breast feeding. An increased risk was found to be associated with ovarian dysfunction leading to infertility and exposure to asbestos and talc. The recent observation that infertile women who used fertility drugs might experience an increased risk for the development of epithelial ovarian cancer should be examined very carefully because of the small number of patients in the study, lack of appropriate information about the type of infertility, drugs used, dosage, and duration of treatment. Because there are no screening tests that are consistently accurate enough to detect ovarian cancer at an early stage, translating the current information into disease prevention requires careful clinical evaluation with a routine follow-up of patients at risk.

Entities:  

Mesh:

Year:  1994        PMID: 8062935     DOI: 10.1016/s0015-0282(16)56928-3

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  8 in total

1.  In vitro regulation of sheep ovarian surface epithelium (OSE) proliferation by local ovarian factors.

Authors:  Salina Yahya Saddick
Journal:  Saudi J Biol Sci       Date:  2012-03-30       Impact factor: 4.219

2.  Fertility drugs and ovarian epithelial cancer: is there a link?

Authors:  R J Paulson
Journal:  J Assist Reprod Genet       Date:  1996-11       Impact factor: 3.412

3.  Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.

Authors:  Ivana Rizzuto; Renee F Behrens; Lesley A Smith
Journal:  Cochrane Database Syst Rev       Date:  2019-06-18

4.  Loss of ovarian function promotes angiogenesis in human ovarian carcinoma.

Authors:  Y S Schiffenbauer; R Abramovitch; G Meir; N Nevo; M Holzinger; A Itin; E Keshet; M Neeman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

Review 5.  Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.

Authors:  Ivana Rizzuto; Renee F Behrens; Lesley A Smith
Journal:  Cochrane Database Syst Rev       Date:  2013-08-13

Review 6.  Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization.

Authors:  Alberto Revelli; Simona Casano; Francesca Salvagno; Luisa Delle Piane
Journal:  Reprod Biol Endocrinol       Date:  2011-02-16       Impact factor: 5.211

7.  Occupational exposure to asbestos and ovarian cancer: a meta-analysis.

Authors:  M Constanza Camargo; Leslie T Stayner; Kurt Straif; Margarita Reina; Umaima Al-Alem; Paul A Demers; Philip J Landrigan
Journal:  Environ Health Perspect       Date:  2011-06-03       Impact factor: 9.031

8.  Primary Ovarian Mesothelioma: A Case Series with Electron Microscopy Examination and Review of the Literature.

Authors:  Luigi Vimercati; Domenica Cavone; Maria Celeste Delfino; Biagio Bruni; Luigi De Maria; Antonio Caputi; Stefania Sponselli; Roberta Rossi; Leonardo Resta; Francesco Fortarezza; Federica Pezzuto; Gabriella Serio
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.